Contributions

  • New York Academy of Sciences - Contributor

Publication

2013 - Wiley Periodicals Inc. on behalf of the New York Academy of Sciences, Malden, MA, Massachusetts

Language

English

Word Count

26,250 words, Guess

Page Count

105 pages

Identifiers

  • ISBN-101573319163
  • ISBN-139781573319164
  • Library of Congress Control Number2014395588
  • OCLC Control Number870084660
  • Better World Books9781573319164
and 1 more

Classifications

  • DDC615.1/9
  • LCCRM301.25 .P4285 2012

Alternate Titles

  • Winners and finalist candidate of the Prix Galien USA 2012

Description

"This Annals volume presents the scientific achievements by winners and finalists of the 2012 Prix Galien USA. Contributions include scholarly summaries from biopharmaceutical industry leaders (GlaxoSmithKline, MethylGene, Bristol-Myers Squibb, Novartis, Optimer Pharmaceuticals, Janssen, Bayer, Merck, UCB Pharma, Medtronic, and Novocure) on pharmaceutical advances in the treatment of a wide range of diseases including advanced melanoma, C. difficile-associated diarrhea, partial-onset seizures, chronic hepatitis C infection, recurrent glioblastoma, and thrombosis-mediated conditions, as well as advances in transcatheter valve technology and ventricular assist devices"--

Subjects

Other Editions

  • Pharmaceutical science to improve the human condition: winners and finalists of the Prix Galien USA 2012Wiley Periodicals Inc. on behalf of the New York Academy of Sciences2013-01-01

Reader Reviews

No reviews yet for this book.

Be the first to share your thoughts!